BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9575343)

  • 1. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
    Yavin EJ; Eisenstein M; Fridkin M
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides derived from the sequence of human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and human leukocyte cathepsin G.
    Yavin EJ; Yan L; Desiderio DM; Fridkin M
    Int J Pept Protein Res; 1996 Nov; 48(5):465-76. PubMed ID: 8956080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid-derived phthalimide and saccharin derivatives as inhibitors of human leukocyte elastase, cathepsin G, and proteinase 3.
    Groutas WC; Chong LS; Venkataraman R; Kuang R; Epp JB; Houser-Archield N; Huang H; Hoidal JR
    Arch Biochem Biophys; 1996 Aug; 332(2):335-40. PubMed ID: 8806743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
    Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
    Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anionic- and lipophilic-mediated surface binding inhibitors of human leukocyte elastase.
    Regan J; McGarry D; Bruno J; Green D; Newman J; Hsu CY; Kline J; Barton J; Travis J; Choi YM; Volz F; Pauls H; Harrison R; Zilberstein A; Ben-Sasson SA; Chang M
    J Med Chem; 1997 Oct; 40(21):3408-22. PubMed ID: 9341916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives.
    Portevin B; Lonchampt M; Canet E; De Nanteuil G
    J Med Chem; 1997 Jun; 40(12):1906-18. PubMed ID: 9191969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of hydrazinopeptides and their evaluation as human leukocyte elastase inhibitors.
    Guy L; Vidal J; Collet A; Amour A; Reboud-Ravaux M
    J Med Chem; 1998 Nov; 41(24):4833-43. PubMed ID: 9822552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human leukocyte elastase by N-substituted tripeptide trifluoromethyl ketones.
    Skiles JW; Fuchs V; Chow G; Skoog M
    Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):365-74. PubMed ID: 2385759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities.
    Hof P; Mayr I; Huber R; Korzus E; Potempa J; Travis J; Powers JC; Bode W
    EMBO J; 1996 Oct; 15(20):5481-91. PubMed ID: 8896442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of porcine pancreatic elastase complexed with FR901277, a novel macrocyclic inhibitor of elastases, at 1.6 A resolution.
    Nakanishi I; Kinoshita T; Sato A; Tada T
    Biopolymers; 2000 Apr; 53(5):434-45. PubMed ID: 10738204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New peptolides from the cyanobacterium Nostoc insulare as selective and potent inhibitors of human leukocyte elastase.
    Mehner C; Müller D; Kehraus S; Hautmann S; Gütschow M; König GM
    Chembiochem; 2008 Nov; 9(16):2692-703. PubMed ID: 18924217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
    Groutas WC; Chong LS; Venkataraman R
    Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the substrate binding site of human leukocyte chymotrypsin (cathepsin G) using tripeptidyl-p-nitroanilide substrates.
    Szabó G; Tözsér J; Aurell L; Elödi P
    Acta Biochim Biophys Hung; 1986; 21(4):349-62. PubMed ID: 3109179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides derived from human C-reactive protein inhibit the enzymatic activities of human leukocyte elastase and cathepsin G: use of overlapping peptide sequences to identify a unique inhibitor.
    Yavin EJ; Fridkin M
    J Pept Res; 1998 Apr; 51(4):282-9. PubMed ID: 9560003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective synthesis of peptidyl trifluoromethyl alcohols and ketones: inhibitory potency against human leucocyte elastase, cathepsin G, porcine pancreatic elastase and HIV-1 protease.
    Amour A; Reboud-Ravaux M; de Rosny E; Abouabdellah A; Bégue JP; Bonnet-Delpon D; Le Gall M
    J Pharm Pharmacol; 1998 Jun; 50(6):593-600. PubMed ID: 9680068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
    Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
    Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase.
    Mulchande J; Oliveira R; Carrasco M; Gouveia L; Guedes RC; Iley J; Moreira R
    J Med Chem; 2010 Jan; 53(1):241-53. PubMed ID: 19904934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of elastin hydrolysis, catalyzed by human leukocyte elastase and cathepsin G, by the Bowman-Birk type soy inhibitor].
    Tikhonova TV; Gladysheva IP; Kazanskaia NF; Larionova NI
    Biokhimiia; 1994 Nov; 59(11):1739-45. PubMed ID: 7873681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.